[1]
|
Locatelli, F., Algeri, M., Trevisan, V. and Bertaina, A. (2017) Remestemcel-L for the Treatment of Graft versus Host Disease. Expert Review of Clinical Immunology, 13, 43-56. https://doi.org/10.1080/1744666X.2016.1208086
|
[2]
|
Kim, S.N., et al. (2015) Galectin-9 Is Involved in Immuno-suppression Mediated by Human Bone Marrow-Derived Clonal Mesenchymal Stem Cells. Immune Network, 15, 241-251. https://doi.org/10.4110/in.2015.15.5.241
|
[3]
|
Zhuo, Y., Zhang, Y.-F., Wu, H.-J., et al. (2017) Interaction between Galectin-9/TIM-3 Pathway and Follicular Helper CD4(+) T Cells Contributes to Viral Persistence in Chronic Hepatitis C. Biomedicine & Pharmacotherapy, 94, 386-393. https://doi.org/10.1016/j.biopha.2017.07.134
|
[4]
|
Li, Y.M., Shi, Y.Y., Li, Y., et al. (2018) Soluble Tim-3 and Gal-9 Are Associated with Renal Allograft Dysfunction in Kid-ney Transplant Recipients: A Cross-Sectional Study. International Immunopharmacology, 55, 330-335.
https://doi.org/10.1016/j.intimp.2018.01.008
|
[5]
|
Jones, E.A., Kinsey, S.E., English, A., et al. (2002) Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells. Arthritis & Rheumatology, 46, 3349-3360. https://doi.org/10.1002/art.10696
|
[6]
|
Dominici, M., Le Blanc, K., Mueller, I., et al. (2006) Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy, 8, 315-317.
https://doi.org/10.1080/14653240600855905
|
[7]
|
Bartholomew, A., Sturgeon, C., Siatskas, M., et al. (2002) Mesenchymal Stem Cells Suppress Lymphocyte Proliferation in Vitro and Prolong Skin Graft Survival in Vivo. Experi-mental Hematology, 30, 42-48.
https://doi.org/10.1016/S0301-472X(01)00769-X
|
[8]
|
Ramasamy, R., Fazekasova, H., Lam, E.W., et al. (2007) Mesenchymal Stem Cells Inhibit Dendritic Cell Differentiation and Function by Preventing Entry into the Cell Cycle. Transplantation, 83, 71-76.
https://doi.org/10.1097/01.tp.0000244572.24780.54
|
[9]
|
Le Blanc, K., Rasmusson, I., Sundberg, B., et al. (2004) Treatment of Severe Acute Graft-versus-Host Disease with Third Party Haploidentical Mesenchymal Stem Cells. The Lancet, 363, 1439-1441.
https://doi.org/10.1016/S0140-6736(04)16104-7
|
[10]
|
Wang, S., Qu, X. and Zhao, R.C. (2012) Clinical Applica-tions of Mesenchymal Stem Cells. Journal of Hematology & Oncology, 5, 19. https://doi.org/10.1186/1756-8722-5-19
|
[11]
|
Wada, J. and Kanwar, Y.S. (1997) Identification and Characterization of Galectin-9, a Novel Beta-Galactoside-Binding Mammalian Lectin. Journal of Biological Chemistry 272, 6078-6086. https://doi.org/10.1074/jbc.272.9.6078
|
[12]
|
Hirashima, M., Kashio, Y., Nishi, N., et al. (2002) Galectin-9 in Phys-iological and Pathological Conditions. Glycoconjugate Journal, 19, 593-600. https://doi.org/10.1023/B:GLYC.0000014090.63206.2f
|
[13]
|
Dardalhon, V., Anderson, A.C., Karman, J., Apetoh, L., et al. (2010) Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Mye-loid Cells. The Journal of Immunology (Baltimore Md 1950), 185, 1383-1392. https://doi.org/10.4049/jimmunol.0903275
|
[14]
|
Sziksz, E., Vannay, A. and Haczku, A. (2012) Galectin-9: A Sup-pressor of Food Allergy. Allergy, 67, 293-295.
https://doi.org/10.1111/j.1398-9995.2011.02774.x
|
[15]
|
Liu, F.-T. and Rabinovich, G.A. (2010) Galectins: Regula-tors of Acute and Chronic Inflammation. Annals of the New York Academy of Sciences, 1183, 158-182. https://doi.org/10.1111/j.1749-6632.2009.05131.x
|
[16]
|
Zhu, C. anderson, A.C., Schubart, A., et al. (2005) The Tim-3 Ligand Galectin-9 Negatively Regulates T Helper Type 1 Immunity. Nature Immunology, 6, 1245-1252. https://doi.org/10.1038/ni1271
|
[17]
|
Bi, S., Earl, L.A., Jacobs, L. and Baum, L.G. (2008) Structural Features of Ga-lectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways. Journal of Biological Chemistry, 283, 12248-12258.
https://doi.org/10.1074/jbc.M800523200
|
[18]
|
Su, E.W., Bi, S. and Kane, L.P. (2011) Galectin-9 Regulates T Help-er Cell Function Independently of Tim-3. Glycobiology, 21, 1258-1265. https://doi.org/10.1093/glycob/cwq214
|
[19]
|
Fernandez-Santamaría, R., Palomares, F., Salas, M., et al. (2019) Ex-pression of the Tim3-Galectin-9 Axis Is Altered in Drug-Induced Maculopapular Exanthema. Allergy, 74, 1769-1779. https://doi.org/10.1111/all.13847
|
[20]
|
Sakai, K., Kawata, E., Ashihara, E., et al. (2011) Galectin-9 Ameliorates Acute GVH Disease through the Induction of T-Cell Apoptosis. European Journal of Immunology, 41, 67-75. https://doi.org/10.1002/eji.200939931
|
[21]
|
Monney, L., Sabatos, C.A., Gaglia, J.L., et al. (2002) Th1-Specific Cell Surface Protein Tim-3 Regulates Macrophage Activation and Severity of an Autoimmune Disease. Nature, 415, 536-541. https://doi.org/10.1038/415536a
|
[22]
|
Ferris, R.L., Lu, B. and Kane, L.P. (2014) Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion. The Journal of Immunology, 193, 1525-1530. https://doi.org/10.4049/jimmunol.1400557
|
[23]
|
Curley, J., et al. (2020) Looking Past PD-L1: Expression of Im-mune Checkpoint TIM-3 and Its Ligand Galectin-9 in Cervical and Vulvar Squamous Neoplasia. Modern Pathology, 33, 1182-1192.
https://doi.org/10.1038/s41379-019-0433-3
|
[24]
|
Oikawa, T., Kamimura, Y., Akiba, H., et al. (2006) Preferential Involvement of Tim-3 in the Regulation of Hepatic CD8+ T Cells in Murine Acute Graft-versus-Host Disease. The Journal of Immunology, 177, 4281-42817.
https://doi.org/10.4049/jimmunol.177.7.4281
|
[25]
|
Reddy, P. and Ferrara, J.L. (2003) Immunobiology of Acute Graft-versus-Host Disease. Blood Reviews, 17, 187-194.
https://doi.org/10.1016/S0268-960X(03)00009-2
|
[26]
|
Benvenuto, F., Ferrari, S., Gerdoni, E., et al. (2007) Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State. Stem Cells, 25, 1753-1760. https://doi.org/10.1634/stemcells.2007-0068
|
[27]
|
Maccario, R., Podestà, M., Moretta, A., et al. (2005) Interaction of Human Mesenchymal Stem Cells with Cells Involved in Alloantigen-Specific Immune Response Favors the Differen-tiation of CD4+ T-Cell Subsets Expressing a Regulatory/Suppressive Phenotype. Haematologica, 90, 516-525.
|
[28]
|
Chinnadurai, R., Copland, I.B., Patel, S.R., et al. (2014) IDO-Independent Suppression of T Cell Effec-tor Function by IFN-γ-Licensed Human Mesenchymal Stromal Cells. The Journal of Immunology, 192, 1491-1501.
https://doi.org/10.4049/jimmunol.1301828
|
[29]
|
Bruno, S., Deregibus, M.C. and Camussi, G. (2015) The Secre-tome of Mesenchymal Stromal Cells: Role of Extracellular Vesicles in Immunomodulation. Immunology Letters, 168, 154-158. https://doi.org/10.1016/j.imlet.2015.06.007
|
[30]
|
Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., et al. (2006) Mesenchymal Stem Cells Inhibit Generation and Function of both CD34+-Derived and Monocyte-Derived Den-dritic Cells. The Journal of Immunology, 177, 2080-2087.
https://doi.org/10.4049/jimmunol.177.4.2080
|
[31]
|
Bernardo, M.E. and Fibbe, W.E. (2013) Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation. Cell Stem Cell, 13, 392-402. https://doi.org/10.1016/j.stem.2013.09.006
|
[32]
|
Zhou, K.J., Guo, S., Tong, S., et al. (2018) Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways. Stem Cells and Development, 27, 1191-1202. https://doi.org/10.1089/scd.2018.0033
|
[33]
|
Gieseke, F., Kruchen, A., Tzaribachev, N., Bentzien, F., Dominici, M. and Muller, I. (2013) Proinflammatory Stimuli Induce Galectin-9 in Human Mesenchymal Stromal Cells to Suppress T-Cell Proliferation. European Journal of Immunology, 43, 2741-2749. https://doi.org/10.1002/eji.201343335
|
[34]
|
Cheng, Z., Wang, L.P., Qu, M.J., et al. (2018) Mesenchymal Stem Cells Attenuate Blood-Brain Barrier Leakage after Cerebral Ischemia in Mice. Journal of Neuroinflammation, 15, 135. https://doi.org/10.1186/s12974-018-1153-1
|
[35]
|
Gonzalez-Pujana, A., Beloqui, A., Javier, A.J., et al. (2022) Mesenchymal Stromal Cells Encapsulated in Licensing Hydrogels Exert Delocalized Systemic Protection against Ulcera-tive Colitis via Subcutaneous Xenotransplantation. European Journal of Pharmaceutics and Biopharmaceutics, 172, 31-40. https://doi.org/10.1016/j.ejpb.2022.01.007
|
[36]
|
Zhao, Y., et al. (2022) Galectin-9 Mediates the Therapeutic Effect of Mesenchymal Stem Cells on Experimental Endotoxemia. Frontiers in Cell and Developmental Biology, 10, Ar-ticle ID: 700702.
https://doi.org/10.3389/fcell.2022.700702
|
[37]
|
Sehrawat, S., et al. (2010) Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response. PLOS Pathogens, 6, e1000882. https://doi.org/10.1371/journal.ppat.1000882
|
[38]
|
Yang, R., Sun, L., Li, C.F., et al. (2021) Galectin-9 Interacts with PD-1 and TIM-3 to Regulate T Cell Death and Is a Target for Cancer Immunotherapy. Nature Communications, 12, 832. https://doi.org/10.1038/s41467-021-21099-2
|
[39]
|
Yang, M., et al. (2020) Checkpoint Molecules Coordinately Restrain Hyperactivated Effector T Cells in the Tumor Microenvironment. Oncoimmunology, 9, Article ID: 1708064. https://doi.org/10.1080/2162402X.2019.1708064
|
[40]
|
Mahanonda, R., et al. (2018) Memory T Cell Subsets in Healthy Gingiva and Periodontitis Tissues. Journal of Periodontology, 89, 1121-1130. https://doi.org/10.1002/JPER.17-0674
|
[41]
|
Qiao, X., et al. (2014) Increased Expression of Tim-3 and Its Ligand Galectin-9 in Rat Allografts during Acute Rejection Episodes. Biochemical and Biophysical Research Communications, 445, 542-548.
https://doi.org/10.1016/j.bbrc.2014.01.167
|
[42]
|
Yin, J., et al. (2020) Increased Galectin-9 Expression, a Prognostic Biomarker of aGVHD, Regulates the Immune Response through the Galectin-9 Induced MDSC Pathway after Alloge-neic Hematopoietic Stem Cell Transplantation. International Immunopharmacology, 88, Article ID: 106929. https://doi.org/10.1016/j.intimp.2020.106929
|
[43]
|
Veenstra, R.G., et al. (2012) Contrasting Acute Graft-versus-Host Disease Effects of Tim-3/Galectin-9 Pathway Blockade Dependent upon the Presence of Donor Reg-ulatory T Cells. Blood, 120, 682-690.
https://doi.org/10.1182/blood-2011-10-387977
|